National and Kapodistrian University of Athens
Κλινική και βακτηριολογική μελέτη της τελιθρομυκίνης και του ABT-773 (σεθρομυκίνης) στη θεραπεία της οξείας ιγμορίτιδος των ενηλίκων
Abstract
dc:descriptionAcute maxillary sinusitis is a common respiratory tract infection, with high morbidity and high cost of therapy in both children and adult population.A number of antimicrobial agents are currently used in the treatment of acute sinusitis, which is typically initiated on an empiric basis with an agent of which spectrum of activity encompasses the most likely causative pathogens. However, decreasing susceptibility and/or the emergence of resistance to existing antimicrobial agents, especially for S.pneumoniae the most likely respiratory pathogen, are steadily increasing problems worldwide. Therefore, a need exists for new antimicrobial agents that not only provide adequate coverage of pathogens most frequently associated with respiratory infections, including resistance strains, but which also have low potential to induce, or select for resistance, convenient dosage regimens and a safe profile for patients in the community. Ketolides have been developed specifically to provide optimal therapy for the treatment of such infections and they appear to be effective at least in in vitro studies. So far, very few clinical trials using these agents have been carried out.Two multicenter, double-blind , randomized clinical trials evaluated the efficacy and safety of the first two ketolides, telithromycin and ABT-773, in the treatment of acute sinusitis in adults. The results of 3 participant centers included in the present study. Our study enrolled 79 patients (41 patients received telithromycin and 38 patients received ABT-773). All subjects had acute maxillary sinusitis, clinically and radiologically confirmed and underwent transantral sinus puncture with culture performed in the aspirate obtained. Eligible patients were subsequently randomized to receive oral treatment with telithromycin in two treatment schedules in telithromycin study and ABT-773 in three treatment schedules in ABT-773 study. The assessment of clinical outcome was performed in five consecutive clinical visits. Patients were considered as cured, if acute maxillary sinusitis- related signs and symptoms and radiological findings were improved or had been completely eliminated. In the present study, clinical and radiological cure rates, bacteriological efficacy rates and adverse events were evaluated separately for each agent, and then the two agents were compared with each other for the aforementioned parameters. According to our results, the majority of patients in each treatment group completed the allocated course of treatment, with a compliance rate of 92,7% in telithromycin group vs 92,1% in ABT-773 group. Clinical and radiological response rates were similar for the two treatment groups and there were no differences between the treatment schedules in each group of therapy. The frequency of adverse events was higher in ABT-773 group. Similar results obtained when clinical and radiological response rates evaluated comparable with the bacteriological response rates. The percentage of culture positive results was higher in ABT-773 group (70,6% vs 29,5% of the telithromycin group). The most commonly reported adverse events involved the gastrointestinal system and were generally of mild intensity. There were no clinical important adverse events in terms of laboratory safety parameters.In conclusion, the two study drugs, appear to be effective and safe in the treatment of acute sinusitis in adults. Greater number of patients is needed in order to find out the most effective as well the safest treatment schedule of each of them. Appropriate use of these agents is necessary in order to preserve their efficacy in the treatment of drug-resistant pathogens in the future.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2003
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Diamantea, Filia
- Διαμαντέα, Φιλία
Subjects
dc:subject × 9Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21729